(redirected from occlusive)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
References in periodicals archive ?
The advent of occlusive dressings reverses a century of medical theory.
The occlusive dressing represents a radical advance in "moist wound healing.
Identify and understand important and diverse types of therapeutics under development for Peripheral Artery Occlusive Disease (PAOD).
Devise corrective measures for pipeline projects by understanding Peripheral Artery Occlusive Disease (PAOD) pipeline depth and focus of Indication therapeutics.
Multiple studies have shown that the overall infection rate underneath occlusive dressings is much lower (2.
based in Wilmington, MA, is a venture-backed medical device company focused on developing breakthrough products for the treatment of vascular occlusive disease.
Lantheus imaging products include the echocardiography contrast agent DEFINITY([R]) Vial for (Perflutren Lipid Microsphere) Injectable Suspension, ABLAVAR([R])(gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease, TechneLite([R])(Technetium Tc99m Generator), Cardiolite([R]) (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), and Thallium 201 (Thallous Chloride Tl 201 Injection).
This acoustic field generates sound waves that rapidly and safely resolve occlusive materials such as blood clots or plaque into micro-particles smaller than red blood cells.
OmniSonics believes that the OmniWave technology will have broad applications in peripheral and coronary vascular occlusive conditions, which afflict tens of millions of people worldwide.
The single patient contact therapeutic wire is designed to deliver low-power acoustic energy 360 degrees around its active 20cm length, targeting occlusive material while leaving healthy arteries and veins unharmed.
We are pleased to realize our goal of launching ABLAVAR[TM], as it can provide patients and clinicians with the first and only product that is approved by the FDA for use with an MRA indication and is specifically indicated for detecting aortoiliac occlusive disease," said Don Kiepert, President and CEO of Lantheus Medical Imaging, Inc.
In addition, the Company has developed an endoluminal graft for minimally invasive repair of vascular trauma, occlusive disease and aneurysms which combines a self-expanding metallic stent with its proprietary elastomeric spun fiber graft.